Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Thousands could be saved by making this small change to heart failure treatment - Giving medication up to a year earlier ...

Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog. New draft guidelines from the ...

New findings from a study of over 400,000 healthy adults indicate that even sodium levels within the high end of the normal ...